Improvement of Satoyoshi syndrome with tacrolimus and corticosteroids.
Endo
K
K
Department of Neurology, Fukushima Medical University School of Medicine, Japan. k-endo@fmu.ac.jp
Yamamoto
T
T
Nakamura
K
K
Hoshi
A
A
Yamanoi
T
T
Watanabe
A
A
Homma
M
M
D000293:Adolescent; D000505:Alopecia / Q000188:drug therapy* / Q000276:immunology; D000568:Amenorrhea / Q000276:immunology; D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D013035:Spasm / Q000188:drug therapy* / Q000276:immunology; D013577:Syndrome; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
D001323:Autoantibodies; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D011239:Prednisolone; D016559:Tacrolimus; D008775:Methylprednisolone